Antipsychotic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018


Antipsychotics are drugs used in the treatment of brain disorders such as schizophrenia, bipolar disorder, and severe depression. According to the New York Times, antipsychotics are one of the largest types of prescribed drugs in the United States with over 3.1 million Americans accounting for a market worth USD 18 billion in 2011 itself. Global estimates suggest that over 1.25% of the global population suffers from psychosis and related disorders. This brings a market of about 7.5 million people suffering from combined disorders of schizophrenia, bipolar disorder, dementia, depression among other rare conditions.

Several recent studies have suggested instances of drug abuse and over prescription of these drugs in the market, particularly in North America. Clinical studies have shown severe drawbacks and addiction to antipsychotic drugs. A serious side effect observed is tardive dyskinesia which is a potentially irreversible movement disorder. These drugs are prescribed for mild symptoms as well, increasing the market for the drugs tremendously.


Antipsychotics market is expected to increase with increasing incidences of Schizophrenia and a very large market of clinical depression. Certain drugs such as Ablify and Seroquel are the topmost in the segment due to their advantage of reduced risk of side-effects. 2012 has observed the end of the several drug patents and it is expected that generic drugs will compete strongly in the market in the coming years. There is an increasing general call in the medical community for adoption of a stronger control while administering these drugs in the coming years. 

Aripiprazole (marketed as Abilify), Asenapine Maleate (marketed as Saphris), Clozapine (marketed as Clozaril), Iloperidone (marketed as Fanapt), Lurasidone (marketed as Latuda), Olanzapine (marketed as Zyprexa), Olanzapine/Fluoxetine (marketed as Symbyax), Paliperidone (marketed as Invega), Quetiapine (marketed as Seroquel), Risperidone (marketed as Risperdal) and Ziprasidone (marketed as Geodon) are the major atypical antipsychotic drugs marketed today. 

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

North America 
Asia Pacific 
Europe
Rest of the World  


This report provides comprehensive analysis of 

Market growth drivers 
Factors limiting market growth
Current market trends 
Market structure
Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Browse All Market Research Report : http://www.transparencymarketresearch.com/

» Read More...

Biochip Products Market And Biochip Services Market - U.S. Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018


Biochips are miniaturized laboratories that can perform thousands of biochemical reactions such as polymerase chain reaction (PCR) simultaneously and are used for a variety of purposes ranging from disease diagnosis to detection of bioterrorism agents. This report estimates the U.S. market for biochips in terms of revenue (USD million) for the period 2012 to 2018, considering 2011 as the base year.


The biochip market is segmented into products market and services market. The biochip market by products is sub-segmented into three types, namely, microarrays, reagents and other products including biochip instruments and software. The biochip products and services market by application is sub-segmented into drug discovery, life science research, IVD testing and other applications including disease management, forensic medicines, drug-of-abuse testing and military and defense applications.

The report provides an analysis of market dynamics, which includes drivers, restraints and opportunities for the biochip market in the U.S. It also analyses the internal and external market factors and their effect on the ecosystem of the biochip market, with the help of Porter’s five force analysis. 

The report includes company profiles of key market players such as Affymetrix, Inc., Life Technologies Corporation, Illumina, Inc. and others. Profiles for all market players have been provided based on parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.
The U.S. biochip market is categorized into the following segments:

Biochip Market, by Segments
Biochip Products Market
Biochip Services Market

Biochip Products Market, by Types
Microarrays
Reagents and Other Consumables
Others (Biochip Instruments and Software)

Biochip Market, by Applications
Drug Delivery
Life Science Research
In Vitro Diagnostic Testing
Others (Disease Management, Forensic Medicine, Defense)


Table of Content

Chapter 1 Preface

1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview

3.1 Market Dynamics
      3.1.1 Market Drivers
               3.1.1.1 Rise in the Application Of Genomics And Proteomics Technologies In Cancer Research
               3.1.1.2 Growth In Drug Discovery, Personalized Medicine And Life Science Research
               3.1.1.3 Impact Analysis Of Market Drivers
      3.1.2 Market Restraints
               3.1.2.1 Low Commercial Acceptability Of Biochips Due To Their High Cost
               3.1.2.2 Availability Of Alternative Technologies Such As Mass Spectrometry And Polymerase Chain Reaction (PCR)
               3.1.2.3 Impact Analysis Of Market Restraints
     3.1.3 Opportunities
               3.1.3.1 New Applications Of Biochips
3.2 Porter’s Five Force Analysis For The U.S. Biochip Market
     3.2.1 Bargaining Power Of Suppliers
     3.2.2 Bargaining Power Of Buyers
     3.2.3 Threat Of New Entrants
     3.2.4 Threat Of Substitutes
     3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis Of The U.S. Biochip Market, By Product Type
3.4 Market Size And Trends
     3.4.1 U.S. Biochip Market, 2011 – 2018 (USD Million)

Browse All Market Research Report : http://www.transparencymarketresearch.com/

» Read More...

Search This Blog

About Me

My photo

The dedicated team of researchers and analysts at Business Research Industry into the Advantage of Knowledge for your company. Data becomes knowledge through the application of Dolcera's optimization process as follows.

Archives

Business Research Industry. Powered by Blogger.